Li et al. reported that CRTC1 mutations and Signature 3 (homologous recombination deficiency) are enriched in chemotherapy-resistant breast cancer, activating JAK-STAT signaling to promote immune evasion [49]. Here, CRTC1 is linked to breast carcinoma.